Medical technology advances at a pace that regulatory frameworks often struggle to match. Devices that reach patients before the regulatory apparatus has fully adapted to the technology they embody create significant legal questions — about liability when things go wrong, what standards of care apply, how informed consent should work when clinical evidence is still being gathered, and how manufacturers, providers, and regulators should navigate uncertainty about safety and efficacy. These questions do not wait for the law to catch up.
Mandelbaum Barrett PC member Peter Levy authored an article in ROI-NJ titled “Future Shock: What Happens When Medical Device Technology Moves Faster Than Regulation Governing It?” Levy practices in the firm’s health care law and related practice areas, advising clients in the healthcare and medical device industries on regulatory, liability, and transactional matters. His ROI-NJ article reflects the firm’s engagement with the complex legal questions arising at the intersection of healthcare innovation and the regulatory policy that governs it.
The Regulatory Gap in Medical Device Oversight
The Food and Drug Administration regulates medical devices through a tiered classification system, with the level of regulatory scrutiny increasing for devices that pose greater patient risks. But even robust regulatory processes can struggle to keep pace with innovation, particularly in areas like digital health, artificial intelligence-enabled diagnostics, and minimally invasive surgical technology. When devices are cleared or approved based on technology standards that quickly become outdated, the regulatory framework may not fully reflect the risk profile of devices actually in clinical use.
The FDA has taken steps to modernize its approach to rapidly evolving technology, including frameworks for software as a medical device and proposed regulatory pathways for AI-enabled medical devices. But the legal questions that arise when technology outpaces regulation — including liability for device failures, professional liability for practitioners using emerging-technology devices, and the standards that govern informed consent discussions — require careful analysis under legal frameworks not always designed with these scenarios in mind.
Liability When Innovation Outpaces the Rules
When a medical device causes harm, liability questions depend on a complex interplay of federal preemption doctrine, state tort law, the device’s regulatory classification and clearance pathway, and the specific circumstances of its use. Devices that received regulatory clearance under standards subsequently revised may be subject to different liability analyses than devices evaluated under current standards. Healthcare providers who use devices beyond their labeled indications take on different legal risks than those using devices strictly as intended and approved.
According to the U.S. Food and Drug Administration, medical device regulation is designed to provide reasonable assurance of safety and effectiveness — but the agency’s approach continues to evolve as the technology landscape changes, and the legal implications of that evolution require ongoing attention from manufacturers, providers, and their legal counsel.
Contact Mandelbaum Barrett PC for Health Care Law Guidance
If you have questions about medical device regulation, healthcare liability, or other legal matters affecting the healthcare and medical device industries in New Jersey, the team at Mandelbaum Barrett PC can help.
Reach out through our contact page to speak with our team. We are here to help healthcare industry clients navigate the complex legal landscape with the guidance their situations require.